Provided by Tiger Trade Technology Pte. Ltd.

GlucoTrack, Inc.

1.64
-0.1000-5.75%
Post-market: 1.62-0.0200-1.22%18:30 EDT
Volume:1.17M
Turnover:2.13M
Market Cap:1.67M
PE:-0.01
High:1.82
Open:1.79
Low:1.51
Close:1.74
52wk High:136.29
52wk Low:1.51
Shares:1.02M
Float Shares:939.90K
Volume Ratio:0.07
T/O Rate:124.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-180.2807
EPS(LYR):-468.2383
ROE:-620.63%
ROA:-164.45%
PB:-0.96
PE(LYR):0.00

Loading ...

Lōkahi Therapeutics, GlucoTrack Unit, Sets Oct. 14 Launch for Qare GLP-1 Comparative Health Platform

Reuters
·
Yesterday

LŌKahi Therapeutics - Qare Expected to be Publicly Available on October 14, 2026

THOMSON REUTERS
·
Yesterday

LŌKahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for Glp-1 Medications, with Public Availability Beginning October 14

THOMSON REUTERS
·
Yesterday

LŌKahi Therapeutics™ Expands AI2 Pipeline™ Program Through Collaboration with Pepperdine E2b™

THOMSON REUTERS
·
Sep 25

GlucoTrack prices 169,388 shares at $2.04 in public offering

TIPRANKS
·
Sep 24

GlucoTrack Prices $3.1 Million Follow-on Offering at $2.04 Per Share

Reuters
·
Sep 24

GlucoTrack, Inc. Announces Pricing of $3 Million Public Offering

THOMSON REUTERS
·
Sep 24

GlucoTrack Unit Lōkahi Therapeutics Expands Ai² Pipeline to External Sponsor Innovate GBM

Reuters
·
Sep 24

LŌKahi Therapeutics™ and GlucoTrack CEO Erik Emerson Provides Strategic Update on Lt-100, AI² Platform Growth and Clinical Development Priorities

THOMSON REUTERS
·
Sep 23

GlucoTrack Director Paul V. Goode Resigns Citing Potential Conflict of Interest

Reuters
·
Sep 19

LŌKahi Therapeutics™ Continues AI² Pipeline™ Division Collaboration with the University of Alabama to Advance Asset Evaluation and Biopharma Talent

THOMSON REUTERS
·
Sep 18

GlucoTrack Amends Private Placement Warrants, Ties Exercise to Shareholder Approval Under NASDAQ Rules

Reuters
·
Sep 15

NASDAQ Trade Halt Volatility Trading Pause at 09:49 Am

Reuters
·
Sep 11

GlucoTrack Announces USD 11.5 Million Convertible Notes Offering

Reuters
·
Sep 11

GlucoTrack Announces $11.5 Million Financing

THOMSON REUTERS
·
Sep 11

GlucoTrack Issues $2 Million 5% Convertible Note to Alto Opportunity Master Fund in Settlement Deal

Reuters
·
Sep 10

GlucoTrack Unit Lōkahi Therapeutics Expands Ai² Platform into Three Divisions

Reuters
·
Sep 08

GlucoTrack announces collaboration with SDSU Fowler College of Business

TIPRANKS
·
Sep 02

LŌKahi Therapeutics™ Expands AI² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business

THOMSON REUTERS
·
Sep 02

GlucoTrack Inc trading halted, news pending

TIPRANKS
·
Aug 29